John Strouse: Grateful for ASH’s Support and for the Privilege of Working with Charity Oyedeji
John Strouse, Associate Professor of Medicine at Duke University Medical Center, shared on LinkedIn:
“I am glad that ASH exists to support researchers through this time of unprecedented disruption to research and the healthcare in the United States and that I have the privilege of working with Charity Oyedeji!”
Quoting American Society of Hematology’s post:
“This past summer, the National Institutes of Health cut funding for a sickle cell disease initiative led by Charity Oyedeji, before it was complete. The Sickle Cell Disease (SCD) Functional Assessment Validation and Refinement (SILVR) Study and the SickleFit Exercise Program were focusing on physical capabilities and independence for patients with SCD. Beyond disrupting patient care, such funding cuts may also discourage researchers, particularly those from underrepresented backgrounds, from pursuing vital work in hematology and SCD research.
Learn more and help protect critical research in hematology here.”
Get the latest ASH updates on Hemostasis Today.
-
Apr 10, 2026, 18:22Chris Hillis: Reflections on My Term as President of the Canadian Hematology Society
-
Apr 10, 2026, 17:59Michelle Leona Cecil: Representing Microhealth at The Coalition for Hemophilia B Annual Symposium
-
Apr 10, 2026, 17:47Lucie Raskin: Comparing VTE Risk in Hormonal Contraceptives at NTHC 2026
-
Apr 10, 2026, 17:39Diverse Voices But Shared Mission – Day 1 of EHC Youth Leadership Workshop
-
Apr 10, 2026, 17:30Make Your Mark at the World Stroke Congress 2026 – World Stroke Organization
-
Apr 10, 2026, 17:23Sofie Abels: Implications for Targeted Screening for Thrombophilia in Young Stroke Patients
-
Apr 10, 2026, 17:08Armghan Ans: 3 Questions Worth Sitting with If You Work in Stroke AI
-
Apr 10, 2026, 17:03William Wallace: Vitamin C Is More Than ”Immune Support”
-
Apr 10, 2026, 16:58Wolfgang Miesbach: Greater Symptom Burden in Women with Bleeding Disorders – Insights from Irish Data